A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

Alkermes Investigational Site, Cullman, Alabama, United States

Alkermes Investigational Site, Los Angeles, California, United States

Alkermes Investigational Site, Boulder, Colorado, United States

Alkermes Investigational Site, Brandon, Florida, United States

Alkermes Investigational Site, Miami, Florida, United States

Alkermes Investigational Site, Winter Park, Florida, United States

Alkermes Investigational Site, Macon, Georgia, United States

Alkermes Investigational Site, Kansas City, Kansas, United States

Alkermes Investigational Site, Newton, Massachusetts, United States

Alkermes Investigational Site, Lansing, Michigan, United States

Alkermes Investigational Site, St Louis, Missouri, United States

Alkermes Investigational Site, Middletown, New Jersey, United States

Alkermes Investigational Site, Cincinnati, Ohio, United States

Alkermes Investigational Site, Wyomissing, Pennsylvania, United States

Alkermes Investigational Site, Columbia, South Carolina, United States

Alkermes Investigational Site, Austin, Texas, United States

Alkermes Investigational Site, San Antonio, Texas, United States

Alkermes Investigational Site, Sugar Land, Texas, United States

Alkermes Investigational Site, Macquarie Park, New South Wales, Australia

Alkermes Investigational Site, Markham, Ontario, Canada

Alkermes Investigational Site, Toronto, Ontario, Canada

Alkermes Investigational Site, Zwolle, Overijssel, Netherlands